Diflunisal

ATC N02BA11 · 6 markets · 31 records

Diflunisal 6 markets · 31 records Forms

US 7 records · 3 strengths

TW 7 records · 3 strengths

  • 250 mgtablet"井田"迪福膜衣錠２５０公絲（待福索）"應元"多樂錠250公絲（待福索）、"政德" 生利痛錠250公絲（待福索）、ANTON TABLET 250MG "EVEREST"(DIFLUNISAL)、DIFLUINE F.C.TABLETS 250MG (DIFLUNISAL) "CHINTENG"、DOLON TABLETS 250MG "Y.Y" (DIFLUNISAL)、GUERTON TABLETS 250MG (DIFLUNISAL)、SENTA TABLETS 250MG (DIFLUNISAL)"GENTLE"、固爾痛錠２５０公絲（待福索） +1 also in US·GB·ES
  • 250 mgcapsule"人人"多樂膠囊２５０公絲（待福索）DOLODE CAPSULES 250MG (DIFLUNISAL) "GCPC"

Records without a stated strength · 1 ILACEN CAPSULE (DIFLUNISAL)、于善膠囊（待福索）

GB 5 records · 2 strengths

  • 250 mgtabletDolobidNovo-Diflunisal 250mg tablets、__no_trade__ also in US·TW·ES
  • 500 mgtabletDolobid also in US

ES 1 records · 1 strengths

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 ATTROGY

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.